Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity

Research in Veterinary Science

Volumn 92, Issue 3, 2012, Pages 501-508

  Bech Nielsen, Gunilla Veslemøy ^a   Hansen, Camilla Hartmann Friis ^a   Hufeldt, Majbritt Ravn ^a,b   Nielsen, Dennis Sandris ^a   Aasted, Bent ^a   Vogensen, Finn Kvist ^a   Midtvedt, Tore ^c   Hansen, Axel Kornerup ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Scanbur Ltd   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antibiotics; C57BL 6 mice; DGGE; Flow cytometry; Glucose tolerance; Type 2 diabetes

Indexed keywords

AMPICILLIN; ERYTHROMYCIN; GLUCOSE;

16S RRNA GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CELL TYPE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DENDRITIC CELL; FEMALE; GENE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GUT MUCOSA IMMUNITY; HELPER CELL; IMMUNITY; INTESTINE FLORA; LYMPHOCYTE COUNT; MICROBIAL DIVERSITY; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; TREATMENT DURATION; WILD TYPE;

AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BLOOD GLUCOSE; BODY WEIGHT; ERYTHROMYCIN; FEMALE; GASTROINTESTINAL TRACT; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL;

MUS;

EID: 84859104629     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2011.04.005     Document Type: Article

References (49)

1. Andrikopoulos S., Blair A.R., Deluca N., Fam B.C., Proietto J. Evaluating the glucose tolerance test in mice. American Journal of Physiology - Endocrinology & Metabolism 2008, 295:E1323-E1332.
2. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the national academy of sciences of the United States of America 2004, 101:15718-15723.
3. Cani P.D., Bibiloni R., Knauf C., Neyrinck A.M., Neyrinck A.M., Delzenne N.M., Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
4. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D.M., Muccioli G.G., Delzenne N.M. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
5. Conde J., Gomez R., Scotece M., Bianco G., Lago F., Gualillo O. Adipocytes and macrophages: two engines powering inflammation in obesity and its complications. Obesity and Metabolism-Milan 2010, 6:5-9.
6. Dahl K., Kirkeby S., d'Apice A.J.F., Matthiassen S., Hansen A.K. The bacterial flora of alpha-gal knock out mice express the alpha-gal epitope comparable to wild type mice. Transplant Immunology 2005, 14:9-16.
7. Ejsing-Duun M., Josephsen J., Aasted B., Buschard K., Hansen A.K. Dietary gluten reduces the number of intestinal regulatory T cells in mice. Scandinavian Journal of Immunology 2008, 67:553-559.
8. Fushuku S., Fukuda K. Gender difference in the composition of fecal flora in laboratory mice, as detected by denaturing gradient gel electrophoresis (DGGE). Experimental Animals 2008, 57:489-493.
9. Fushuku S., Fukuda K. Inhomogeneity of fecal flora in separately reared laboratory mice, as detected by Denaturing Gradient Gel Electrophoresis (DGGE). Experimental Animals 2008, 57:95-99.
10. Guo, J., Jou, W., Gavrilova, O., Hall, K.D., 2009. Persistent Diet-Induced Obesity in Male C57BL/6 Mice Resulting from Temporary Obesigenic Diets. Plos One 4.
11. Hansen A.K. The aerobic bacterial flora of laboratory rats from a Danish breeding centre. Scandinavian Journal of Laboratory Animal Science 1992, 19:59-68.
12. Hansen A.K. Antibiotic treatment of nude rats and its impact on the aerobic bacterial flora. Laboratory Animals 1995, 29:37-44.
13. Hansen, A.K., Ejsing-Duun, M., Aasted, B., Josephsen, J., Christensen, G.B., Vogensen, F.K., Hufeldt, M., Buschard, K., 2009. The impact of the post natal gut microbiota on animal models. Proceedings of the Tenth FELASA Symposium and the XIV ICLAS General Assembly & Conference, Cernobbio, Italy, 11-14 June 2007 95-99.
14. Hansen A.K., Ling F., Kaas A., Funda D.P., Farlov H., Buschard K. Diabetes preventive gluten-free diet decreases the number of caecal bacteria in non-obese diabetic mice. Diabetes-Metabolism Research & Reviews 2006, 22:220-225.
15. Hooper L.V., Gordon J.I. Commensal host-bacterial relationships in the gut. Science 2001, 292:1115-1118.
16. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. Journal of Clinical Investigation 1995, 95:2409-2415.
17. Hotamisligil G.S., Budavari A., Murray D., Spiegelman B.M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. Journal of Clinical Investigation 1994, 94:1543-1549.
18. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
19. Hufeldt M.R., Nielsen D.S., Vogensen F.K., Midtvedt T., Hansen A.K. Family relationship of female breeders reduce the systematic inter-individual variation in the gut microbiota of inbred laboratory mice. Laboratory Animals 2010, 44:283-289.
20. Hufeldt M.R., Nielsen D.S., Vogensen F.K., Midtvedt T., Hansen A.K. Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors. Comparative Medicine 2010, 60:336-342.
21. Hundal R.S., Petersen K.F., Mayerson A.B., Randhawa P.S., Inzucchi S., Shoelson S.E., Shulman G.I. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. Journal of Clinical Investigation 2002, 109:1321-1326.
22. Inoue R., Otsuka M., Ushida K. Development of intestinal microbiota in mice and its possible interaction with the evolution of luminal IgA in the intestine. Experimental Animals 2005, 54:437-445.
23. Karaca M., Magnan C., Kargar C. Functional pancreatic beta-cell mass: Involvement in type 2 diabetes and therapeutic intervention. Diabetes & Metabolism 2009, 35:77-84.
24. Kelly D., King T., Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutation Research 2007, 622:58-69.
25. Lauritzen L., Hufeldt M.R., Aasted B., Hansen C.H.F., Midtvedt T., Buschard K., Hansen A.K. The impact of a germ free perinatal period on the variation in animal models of human inflammatory diseases. Scandinavian Journal of Laboratory Animal Science 2010, 37:43-54.
26. Livingston E.H. Obesity and its surgical management. American Journal of Surgery 2002, 184:103-113.
27. Macpherson A.J., Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nature Reviews 2004, 4:478-485.
28. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
29. Membrez M., Blancher F., Jaquet M., Bibiloni R., Cani P.D., Burcelin R.G., Corthesy I., Mace K., Chou C.J. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. Faseb Journal 2008, 22:2416-2426.
30. Nielsen D.S., Teniola O.D., Ban-Koffi L., Owusu M., Andersson T.S., Holzapfel W.H. The microbiology of Ghanaian cocoa fermentations analysed using culture-dependent and culture-independent methods. International Journal of Food Microbiology 2007, 114:168-186.
31. Norin E., Midtvedt T. Intestinal microflora functions in laboratory mice claimed to harbor a " normal" intestinal microflora. Is the SPF concept running out of date?. Anaerobe 2010, 16:311-313.
32. Ovreas L., Forney L., Daae F.L., Torsvik V. Distribution of bacterioplankton in meromictic Lake Saelenvannet, as determined by denaturing gradient gel electrophoresis of PCR-amplified gene fragments coding for 16S rRNA. Applied and Environmental Microbiology 1997, 63:3367-3373.
33. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
34. Sartor R.B. Role of commensal enteric bacteria in the pathogenesis of immune-mediated intestinal inflammation: lessons from animal models and implications for translational research. Journal of Pediatric Gastroenterology & Nutrition 2005, 40:S30-S31.
35. Schreyer S.A., Wilson D.L., LeBoeuf R.C. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 1998, 136:17-24.
36. Sindelar D.K., Chu C.A., Venson P., Donahue E.P., Neal D.W., Cherrington A.D. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 1998, 47:523-529.
37. Stappenbeck T.S., Hooper L.V., Gordon J.I. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. [see comment]. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:15451-15455.
38. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annual Review of Immunology 2003, 21:335-376.
39. Tlaskalová-Hogenoá H., Stepánková R., Hudcovic T., Tucková L., Cukrowska B., Lodinová-Zadniková R., Kozáková H., Rossmann P., Bártová J., Sokol D., Funda D.P., Borovská D., Reháková Z., Sinkora J., Hofman J., Drastich P., Kokesová A. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunology Letters 2004, 93:97-108.
40. Toye A.A., Lippiat J.D., Proks P., Shimomura K., Bentley L., Hugill A., Mijat V., Goldsworthy M., Moir L., Haynes A., Quarterman J., Freeman H.C., Ashcroft F.M., Cox R.D. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 2005, 48:675-686.
41. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
42. Vaahtovuo J., Toivanen P., Eerola E. Study of murine faecal microflora by cellular fatty acid analysis; effect of age and mouse strain. Antonie van Leeuwenhoek 2001, 80:35-42.
43. Vaahtovuo J., Toivanen P., Eerola E. Bacterial composition of murine fecal microflora is indigenous and genetically guided. Fems Microbiology Ecology 2003, 44:131-136.
44. Vaarala O., Atkinson M.A., Neu J. The " perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008, 57:2555-2562.
45. Varga O., Harangi M., Olsson I.A.S., Hansen A.K. Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview. Obesity Reviews 2010, 11:792-807.
46. Visek W.J. The mode of growth promotion by antibiotics. Journal of Animal Science 1978, 46:1447-1469.
47. Winzell M.S., Ahren B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004, 53:S215-S219.
48. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., Shoelson S.E. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001, 293:1673-1677.
49. Zhang Y.Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homolog. Nature 1994, 372:425-432.